Tailored therapies for primary immunodeficiencies.
Cinicola B, Pulvirenti F, Brindisi G, Marseglia GL, Castagnoli R, Foiadelli T, Caffarelli C, Licari A, Miraglia Del Giudice M, Zicari AM, Duse M, Cardinale F.
Cinicola B, et al.
Acta Biomed. 2021 Nov 29;92(S7):e2021520. doi: 10.23750/abm.v92iS7.12406.
Acta Biomed. 2021.
PMID: 34842590
Free PMC article.
Moreover, in the last years, the approach of conventional treatments such as immunoglobulin replacement therapies has evolved and the indication has expanded to new diseases, leading to individualized strategies to both improve infection control and quality of life. ...
Moreover, in the last years, the approach of conventional treatments such as immunoglobulin replacement therapies has evolved and the …